ArticleDiscover oncology2025
Mapping the global intellectual landscape of inflammatory tumor microenvironment in colorectal cancer pathogenesis and prognostic research since this century.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated multi-omics characterization of SPTBN2 overexpression reveals its pro-tumorigenic role and immune microenvironment remodeling in colorectal cancer.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundColorectal cancer (CRC) is one of the most prevalent gastrointestinal tumors worldwide. Complex interactions between tumor microenvironment (TME) and host inflammatory response influence CRC progression and recurrence. The current study provides a comprehensive bibliometric visualization of the current state and frontier trends of inflammatory TME in CRC. MATERIALS AND
methodsScientific publications on the inflammatory TME in CRC from 2000 to 2024 were retrieved from the Web of Science Core Collection (WoSCC) database. Biblioshiny software was mainly applied for visualization and analysis of literature. CiteSpace software and VOSviewer software were used to validate the results.
resultsA total of 1593 articles related to CRC inflammatory TME have been retrieved since the 21st century. Cancers and Frontiers in Immunology were the two most popular journals, and Cancer Research is the most cited journal. Mcmillan DC, Park JH and Mantovani A were the most academic influential authors in inflammatory TME in CRC.
conclusionsThis study preliminary visualize the association of inflammatory TME with CRC through bibliometric analysis. The immunomodulatory mechanisms in IBD-associated carcinogenesis, NF-κB-mediated TME remodeling in tumor progression, and CRC patient stratification and precision therapeutics were three hotspots for future research endeavors on the inflammatory TME in CRC research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.